The dıagnostıc Value of Serum autotaxın Level ın Colorectal Cancer
NCT06091592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129
Last updated 2023-10-19
Summary
Colorectal cancer is one of the most common causes of cancer-related death. Early diagnosis is extremely important in terms of treatment and mortality. In this study, we investigated the diagnostic value of serum autotaxin levels in colorectal cancer.
Conditions
- Colo-rectal Cancer
Interventions
- OTHER
-
Serum autotaxın levels
Autotaxin molecule is a nucleotide pyrophosphatase/phosphodiesterase enzyme.
Sponsors & Collaborators
-
Diskapi Yildirim Beyazit Education and Research Hospital
lead OTHER_GOV
Principal Investigators
-
ismail o kaya · Dışkapı Yıldırım Beyazıt training and research hospital
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-30
- Primary Completion
- 2021-11-20
- Completion
- 2021-12-25
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer
NCT02077296 ·Status: COMPLETED
-
A Translational Study for Locoregional Recurrence of T4 Colon Cancer
NCT06958926 ·Status: RECRUITING
-
The Continuing Care Needs in Colorectal Cancer Patients in Different Stages
NCT00961129 ·Status: UNKNOWN
-
New Genes in the Carcinogenesis of Colorectal Cancer
NCT03261752 ·Status: UNKNOWN
-
AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy
NCT07049627 ·Status: COMPLETED
-
T Helper Cytokines in End Stage Colorectal Cancers
NCT04540146 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
NCT02882269 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluating Factors Affecting Survival in Colon and Rectum Cancer
NCT05388513 ·Status: COMPLETED
-
Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer
NCT00254683 ·Status: UNKNOWN ·Phase: PHASE2
-
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer
NCT02202928 ·Status: UNKNOWN ·Phase: PHASE2
-
CRC Post-surgical Assessment and Recurrence Monitoring
NCT03334890 ·Status: UNKNOWN
-
A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis
NCT01269229 ·Status: COMPLETED ·Phase: PHASE2
-
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT03659448 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
NCT01212510 ·Status: COMPLETED ·Phase: NA
-
Factors Affecting the Time to Start Postoperative Chemotherapy in Colorectal Cancer
NCT04885283 ·Status: COMPLETED
-
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
NCT05015296 ·Status: UNKNOWN
-
Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery
NCT03958435 ·Status: UNKNOWN
-
Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer
NCT01929499 ·Status: UNKNOWN ·Phase: PHASE2
-
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
NCT03829852 ·Status: COMPLETED
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
NCT05924282 ·Status: COMPLETED
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy
NCT03013972 ·Status: UNKNOWN
-
RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer
NCT05578287 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
NCT06540027 ·Status: ENROLLING_BY_INVITATION